NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Celebrates Listing and Autism Awareness
The PaxMedica (NASDAQ: PXMD) team recently gathered to ring the closing bell on the NASDAQ exchange, where its shares began trading in August 2022. The April 19 event coincided with Autism Awareness Month. “We’re aggressively working towards our most important goal: developing the first treatment for the core symptoms of autism spectrum disorder, and we will not stop until we get there,” PaxMedica CEO Howard Weisman said in his opening remarks. For more information, visit https://nnw.fm/GVNxR About PaxMedica Inc. PaxMedica is a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (“APT”) for the treatment of disorders…







